Medical devices are AI One of the important areas of application, with innovative products emerging continuously. From the perspective of the medical device industry, currently AI+ What are the key directions of investment in medical product research and development? Where does the R&D funding mainly come from? What is the return on investment? Looking at specific sub-sectors, which areas are experiencing fierce competition, and which ones are relatively blue oceans? AI In the field of medical devices, practical applications are gradually shifting from scenario exploration to commercialization transformation. How do you view this? AI What are the current dilemmas of high R&D investment in medical products and difficulties in commercialization? What are the solutions for the future? 2020 First medical record of the year AI Three types of certificates start, AI The supervision of medical equipment is constantly developing. In the future, where else do we need to further improve it?     Frost & Sullivan Frost & Sullivan Xu Chao, project manager of the Life Sciences Business Unit of Frost & Sullivan Greater China, was interviewed by China Securities Journal to discuss the “ AI+ Medical & rdquo; industry development.   China Securities Journal   * Click at the end of the article Read the original text View the full report     Q :    From the perspective of the medical device industry, currently AI+ What are the key directions of investment in medical product research and development? Where does the R&D funding mainly come from? What is the return on investment? Looking at specific sub-sectors, which areas have fierce competition and which ones are relatively blue oceans? Currently, clinical needs are developing towards precision, minimally invasive techniques, intelligence, and remoteization. Consequently, medical devices and AI The integration of technologies is also becoming increasingly close-knit, AI Technology has been widely applied in various sub-sectors of medical devices. AI+ The investment focus on medical product research and development is mainly concentrated in auxiliary diagnosis and imaging recognition, intelligent medical devices, personalized medicine, etc. Driven by the increasing maturity of technology and the improvement of policy systems, medical devices AI The application of the track is gradually moving from the initial development stage to a deeper implementation phase. At the same time, rapid development cannot be separated from the continuous attention and vitality injected into the medical device sector by primary or secondary markets. 2021 In [year], Eagle Vision Technology made a splash at the Hong Kong Stock Exchange, becoming a healthcare AI The first stock listed. Looking at the sub-sectors, AI Medical imaging has become a popular application area in recent years. Pulmonary nodules and fundus screening are two disease areas that companies are widely deploying in at present. In addition, the era of robotics is subverting various traditional surgeries and presenting trends such as informatization, intelligence, and minimally invasive techniques. AI The surgical robot industry is also developing rapidly. Currently, the main technical bottlenecks are insufficient data volume and algorithmic interpretability, which affect the promotion scope and application effectiveness of artificial intelligence in the medical device industry. Products and related enterprises that can break through these bottlenecks in the future will bring new development momentum to the industry.     Q :    AI In the field of medical devices, practical applications are gradually shifting from scenario exploration to commercialization. What's your view? AI What are the current dilemmas of high R&D investment in medical products and difficulties in commercialization? What solutions do you think there are for the future? AI The practical application in the field of medical devices is shifting from scenario exploration to commercialization, which is a positive trend that demonstrates its market potential and practical value. However, at present AI Medical products indeed face the dilemma of high R&D investment and difficult commercialization, mainly due to various factors such as technological maturity, business model, and regulatory policies. Firstly, from the perspective of business model, AI The research, development, and commercialization of medical products require the construction of a complete industrial chain, including upstream data collection, processing, and analysis, midstream algorithm model development and optimization, as well as downstream medical service provision and market promotion. In this process, each link needs to cooperate closely to form an effective business model. Secondly, technological breakthroughs are also key to solving the challenges of commercialization. Currently, AI Medical products need further improvement in terms of algorithm accuracy, stability, and reliability. In addition, data security and privacy protection are also AI An important consideration in the development of medical technology. Strengthen research and application of data governance and privacy protection technologies to ensure the security and compliance of patient data. Furthermore, regulatory policies also have an impact AI An important factor in the commercialization and implementation of medical products. With AI With the rapid development of technology, regulatory authorities need to formulate and improve corresponding laws, regulations, standards, and norms to AI The commercialization of medical products provides strong institutional support.     Q :    from 2020 First medical record of the year AI Three types of certificates start, AI The supervision of medical equipment is constantly developing. In the future, where else do we need to further improve it? since 2020 year 1 In the month, Keya Medical obtained Class III medical device certification, marking China AI Medical devices have entered the commercialization stage. As regulatory pathways become increasingly clear, the number of approvals for Class III certificates will increase. As of 2023 year 6 month 30 day, already 63 The product has successfully obtained Class 3 certificates. More and more III The approval of the class certificate also means that the industry's focus is shifting from research and development to commercial implementation. In recent years AI The regulatory mechanism for medical devices has made remarkable progress, but there is still room for continuous improvement in several areas. For instance, classification management and risk grading strategies can be implemented to clarify the scope of use and limitations for different types of large models. 2022 The "Guiding Principles for the Registration and Review of Artificial Intelligence Medical Devices" (hereinafter referred to as the "Principles") promulgated in [year] AI The specific positioning and uses of medical device products have been carefully divided and supplemented with explanations, providing clear guidance for supervision. In terms of data sources, the 'Principles' detail three types of data sources, all of which share the common characteristic of being objective data used for medical purposes. To ensure the accuracy and reliability of data, it is necessary to strengthen the review of training data sources and quality, clarify compliance requirements for data collection and use, thereby effectively preventing data abuse and privacy leaks. In addition, an accountability system for medical large models can be explored to ensure clear and traceable responsibilities. Through the implementation of these measures, we will be able to further improve. AI The regulatory mechanism for medical devices ensures their safety and effective service to public health.   * This interview has been published in 'China Securities Journal', with reporter Li Mengyang and the original title being '    " AI+ Medical ”Rising Tides Medical device companies explore commercial models    >>

The First Symposium on Research and Development of Small Molecule Drugs 2024 year 4 month 25 - 26 On InnoXBio2024 The First Small Molecule Drug Research and Development Forum was successfully held in Nanjing. The conference focused on biomarkers and translational medicine, 'undruggable' targets, the development of small molecule drugs for tumors and non-tumors, ADC Coupling technology, License In and Out Topic-based, eight thematic forums are launched, inviting 70+ Guest Speakers 1,000+ Industry experts, exploring together and seeking common development for the industry.   Frost & Sullivan Frost & Sullivan Chen Zhenrong, consulting director of Frost & Sullivan's Life Sciences Practice in Greater China, was invited to attend the event and participate in “ ADC The special forum on "Coupling Technology and Drug Development", and on ADC Delivered a speech on "The Global Market Structure and Trends of Pharmaceuticals". Consulting Director, Life Sciences Business Unit, Frost & Sullivan Greater China Region Chen Zhenrong Chen Zhenrong introduced, globally ADC Primary market financing in the pharmaceutical sector 2020 The year saw a surge, with capital inflows driving industrial development. At the same time, ADC drug License-out of the Mainland With frequent incidents and a phenomenon-level impact, 2023 Chinese drugs in License-out of the Mainland The total down payment exceeds for the first time IPO listing Fundraising. Globally ADC Looking at the clinical R&D situation in the field, ADC The R&D in the field is accelerating, new research results are emerging continuously. After security verification, effectiveness has become a core competitiveness, and there is a high richness of innovative targets. Currently, China has become ADC An important innovation source in the field, with many enterprises deploying efforts here. However, currently, there is a high degree of homogenization among targets, leading to fierce competition. Source: Analysis by Frost & Sullivan Chen Zhenrong pointed out, ADC The development involves antibodies, conjugates, payloads, and coupling technologies, presenting many challenges in research and production. With the development of dual-target antibodies, the optimization of conjugates, the emergence of protein degrading agents and other payloads, and the adjustment of site-specific quantitative coupling technologies, ADC The safety and effectiveness of drugs will be enhanced. New generation ADC The product will possess a larger therapeutic window, superior specificity and cytotoxicity, as well as updated treatment mechanisms, overall ADC The pharmaceutical market is expected to continue growing, with broad market prospects.   More exciting moments from the event arena   About Frost & Sullivan's Life Sciences Practice The Life Sciences Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the field of life sciences. Leveraging Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, the Life Sciences Practice has unique core advantages in investment and financing services for the life science industry. The Life Sciences Practice has a wide range of corporate clients in China and in the past 20 In the year, a vast customer network was established, accumulating extensive project experience in various subfields of life sciences. Project types include Knowledge Center projects (in-depth content, promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising writing), market research, market value management, strategic consulting, etc. We also cooperate with well-known domestic and international information platforms and investment and financing institutions to provide one-stop solutions for enterprises in specialized fields such as pharmaceuticals and medical devices, attracting widespread attention from investors.

In recent years, the baking industry has seen an accelerated reshuffle of brands. Brands such as "Panda Does Not Leave," "Tiger Head Bureau," and "Mo Mo's Pastries Bureau" have gone from rapid expansion to desperate survival in just a few years, with some even closing down. How do we view this phenomenon? What role has capital played in it? What is the connection between the entry of capital and the accelerated reshuffle of the industry? What are the advantages and disadvantages of capital entry? At the same time, some baking brands have established themselves through different marketing strategies. What are the differences in their marketing strategy directions? Why can they stand firm in the baking industry? What are your views on the future of the baking industry? Which type of bakery can continue to survive and develop? How should bakery stores respond to today's economic and consumption patterns?     Frost & Sullivan Frost & Sullivan Lou Lei, Executive Director of Frost & Sullivan's Greater China Region (hereinafter referred to as 'Frost & Sullivan'), was interviewed by CCTV Finance Channel, sharing his observations on the baking market.   CCTV Finance   * Click at the end of the article Read the original text View the full report     Q :    In recent years, the baking industry has seen a rapid reshuffle of brands, with names such as 'Panda No Go', 'Tiger Head Bureau', and 'Mo Mo Dimsum Bureau' experiencing a shift from rapid expansion to desperate survival in just a few years, with some even going bankrupt. How do you view this phenomenon? Behind this phenomenon is the result of multiple factors interacting with each other, which includes not only changes in the external environment but also reveals deficiencies in brand internal management. Why can it expand rapidly in a short period of time: 1 Brand rejuvenation and precise positioning: These are typical new consumer brands that have not been around for long, but have quickly gained the favor of young consumers with their youthful brand image and precise product positioning. For example, Hooters' macaroni tiger rolls and Panda's door-to-door service stand out in the market with their unique selling points. 2 Online and offline integration with internet traffic strategies: New consumer brands deeply understand the art of internet traffic, utilizing an integrated online and offline business model to fully leverage social media, short videos, and other internet tools for rapid brand dissemination and sales growth. 3 Explosive expansion fueled by capital: In addition, 2020 Year-end 2022 Against the backdrop of a new wave of consumer investment in recent years, a large number of new consumer brands have gained the favor of capital. The resolution of funding issues has enabled these brands to achieve explosive expansion in a short period. Why have we now reached a situation where we are left with no way out: 1 The consumer environment has returned to rationality: As the market matures, consumers are making more rational choices about products and no longer blindly pursue popular online influencers and best-selling products. The baking market has also shown a trend towards returning to value for money, putting some high-priced and low-consumption frequency online influencer baked products under market pressure. 2 The return of capital to rationality and the cooling of investment enthusiasm: As the capital market's enthusiasm for large consumer investments gradually wanes, brands find it increasingly difficult to obtain substantial capital support, their expansion speed slows down, and they even face the risk of capital chain breakage. 3 Insufficient enterprise management and team capabilities: Due to their short establishment time, these brands are not yet mature in talent cultivation and management systems, leading to problems such as management chaos and unstable teams during rapid expansion. 4 Over-reliance on traffic and marketing: Brands that overly depend on traffic and marketing methods develop their business too much based on external factors. Once the market environment changes, it becomes difficult for brands to cope. At the same time, excessive marketing can also have a negative impact on brand reputation and profits. 5 There are significant weaknesses in the business model: Some brands have flaws in their business models, such as over-reliance on online food delivery platform traffic. Once platform policies change or competition intensifies, it becomes difficult for brands to maintain their market position. In summary, the phenomenon of brand reshuffling in the baking industry is an inevitable result of market development. The baking industry has broad prospects, and for new consumer brands, to stand firm in the fierce market competition, they need to examine their internal models and balance development speed with quality. In the future, brands should continue to innovate, improve product quality, and focus on consumer experience to achieve sustainable development.     Q :    What role has capital played in this? What is the connection between capital entry and the accelerated reshuffling of industries? What are the advantages and disadvantages of capital entry? In the process of brand reshuffle in the baking industry, capital has played a crucial role. Take Hutouju as an example; it gained control within a short period of time, including IDG Multiple rounds of financing, including Sequoia Capital and Challenger Capital, have rapidly driven the valuation upwards. 20 Hundreds of millions. The injection of these capitals has provided a strong financial backing for emerging brands, promoted rapid brand expansion, and quickly established a powerful brand influence in the market. However, the entry of capital has also brought about a double-edged sword effect. On one hand, capital provides valuable resources for brands, helping them quickly occupy markets and enhance brand power; on the other hand, capital also sets higher demands on brands, especially in terms of business models and operational management. This high-pressure test forces brands to deal with challenges in supply chain management, store staff management, new product development, market expansion, and other aspects within a short period. If the brand's management team is not fully prepared and able to cope with these challenges, rapid capital investment may instead become a burden on the brand. Once a balance cannot be found between quality and scale, the brand may expose its weaknesses due to rapid expansion, and even lead to a backlash against brand value. Therefore, when facing capital entry, brands should not only see the opportunities brought by capital but also be vigilant about the challenges it poses. Only by focusing on internal strength cultivation and improving management levels and operational efficiency can brands remain invincible in the fierce market competition.     Q :    At the same time, there are also some baking brands that have established themselves through different marketing strategies. Can you briefly discuss the differences in marketing strategy directions among these brands? Why are they able to stand firm in the baking industry? The current domestic baking market shows a diversified positioning and development direction, with three strategies particularly prominent: affordable, high-end, and online celebrity brands. Although these strategies are different, they each successfully found their footing in the market. Affordable brands: Such brands focus on cost-effectiveness and healthy, stable quality as their core competitiveness. They differentiate themselves from time-limited products by offering affordable and reliable products, mainly competing in markets such as supermarkets, snacks, and school meals. The essence of this strategy lies in meeting consumers' basic needs for daily consumption and winning market reputation with sustained and stable quality. High-end brands: High-end baking brands are committed to creating an image of imported, professional, and masterpieces. By emphasizing the uniqueness and high quality of their products, they adopt a similar competitive strategy with high-end dining venues such as Western restaurants. The success of this strategy lies in meeting consumers' pursuit of a high-quality life and consolidating their market position by strengthening positioning. Internet celebrity brand: Online celebrity baking brands have become a hot topic in the consumer goods industry in recent years. They have rapidly attracted a large amount of attention through innovative marketing strategies and have become hot topics on social media. However, online celebrity brands also face the dual-edged sword effect. Before becoming an online celebrity, brands usually aim at becoming internet celebrities and focus on marketing. But once they become online celebrities, how to get rid of the online celebrity label and achieve sustainable development becomes an important challenge for brands. For online celebrity brands, marketing is undoubtedly the key to breaking through the market. However, relying solely on marketing is not enough to support the long-term development of a brand. After becoming an online celebrity, the brand needs to ensure that its products themselves are competitive enough to withstand the scrutiny of consumers and the market. At the same time, the brand also needs to find a balance between popularity and development speed, maintaining market attention while controlling expansion rates to ensure profitability and brand image stability. In summary, whether it is an affordable, high-end, or internet-famous baking brand, the key to their success in the market lies in accurately identifying their positioning and formulating appropriate marketing strategies around that. At the same time, brands also need to continuously enhance their own strength to ensure the sustained competitiveness of their products, services, and brand image.     Q :    What are your views on the future of the baking industry? Which type of bakery can continue to survive and develop? How should bakeries respond to today's economic and consumption trends? According to Frost & Sullivan's calculations, the baking industry has more than 2,000 The market scale is hundreds of millions, with an average annual growth rate approaching 10% Its potential cannot be ignored. However, the highly decentralized, regionalized, and segmented characteristics of the market also bring unique challenges and opportunities to the baking industry. Looking at the benchmark enterprises in the current market, whether they are time-honored brands such as Daoxiangcun, Xinghualu, and Juxiangyuan, regional brands like Haolilai and Xingfu Western Biscuits, or imported foreign brands like Brioche and Paris Baguette, each has carved out a niche in the market with its unique competitive strategies and target customer groups. These successful cases demonstrate that different types of baking enterprises can survive and develop in different ways. For the future development direction of bakeries, there are several suggestions: 1 Steadfast progress: In a highly competitive market, maintaining a steady development pace is crucial. By continuously optimizing products and services, enhancing brand reputation, attracting and retaining consumers. At the same time, paying attention to market dynamics and changes in consumer needs, flexibly adjusting business strategies. 2 Actively embrace young consumers: Young consumers are an important consumer group in the baking market. Brands need to learn and adapt to the preferences and habits of the new generation, using new media channels such as social media and short videos for marketing and promotion. At the same time, pay attention to fashion trends and innovations, continuously developing products and services to meet the personalized needs of young consumers. 3 Adhere to the original intention of the product: While pursuing innovation and fashion, brands must not neglect the essence of their products. High-quality products are the foundation for a brand to stand firm in the market. Brands need to always adhere to the original intention of their products, continuously improve product quality and taste, and win the trust and loyalty of consumers. In addition, when facing today's economic and consumption trends, bakeries should also pay attention to the following points: 1 Cost Control: Against the backdrop of fluctuating raw material prices and rising labor costs, brands need to strengthen cost control and improve operational efficiency. By optimizing supply chain management and reducing inventory costs, they can lower costs and enhance profitability. 2 Digital Transformation: Utilize advanced technologies such as big data and artificial intelligence for digital transformation to improve brand operational efficiency and consumer experience. For instance, understand consumer needs and market trends through data analysis to formulate more precise marketing strategies; improve production efficiency and product quality through smart devices, etc. 3 Sustainable Development: With the increasing awareness of environmental protection, brands need to pay attention to sustainable development issues. Measures such as using environmentally friendly materials and packaging, and promoting green production methods can help enhance brand image and consumer loyalty. In summary, the baking industry will continue to maintain a decentralized, stratified, and diverse competitive landscape in the future. Brands need to develop appropriate competitive strategies and development directions based on their own characteristics and market demands, while also paying attention to issues such as cost control, digital transformation, and sustainable development to achieve long-term stable development. * This interview has been broadcast on CCTV Finance Channel. The reporter is Wang Yannan, and the original title was 'Observations on the Baking Market'. "Panda doesn't leave" cake store closes down on a large scale Baking Track Accelerated Rebranding', 'Baking Market Observation' Meet consumers' diversified needs Baking merchants adjust strategies to stay ahead of the curve

Why has the low-altitude economy suddenly heated up? It's because of China's first eVTOL aircraft Is it airworthiness certification? What does 'certification' mean for the low-altitude economy? From 'certification' to large-scale commercial operations, what other challenges remain? The core of electric vehicles is the 'three electrifications': eVTOL aircraft Is the core also three-electricity-related? Currently in China eVTOL aircraft Have the motors and flight controllers been localized? What are the difficulties in motor and flight controller development? eVTOL aircraft What type of battery is being used, ternary or lithium iron phosphate? From the perspective of battery energy density and consistency, is ternary more suitable? eVTOL aircraft Are standard electric vehicle batteries being used, or are customized batteries being utilized? Currently eVTOL aircraft In terms of technical routes, there are mainly multi-rotor, compound wing, and tiltrotor technologies. What are the respective advantages and disadvantages of these technologies? Is the low-altitude economy currently well-established in terms of laws and regulations? eVTOL aircraft Are there any legal restrictions on operating at low altitudes?     Frost & Sullivan Frost & Sullivan Zhang Zhiwei, Executive Director of Frost & Sullivan Greater China, was interviewed by the Daily Economic News to discuss eVTOL aircraft development.   Daily Economic News   * Click at the end of the article Read the original text View the full report     Q :    Why has the low-altitude economy suddenly heated up? It's because of the first domestic eVTOL aircraft Is it airworthiness certification? What does 'certification' mean for the low-altitude economy? From 'certification' to large-scale commercial operations, what other challenges remain? The low-altitude economy is a comprehensive economic form that drives the integrated development of related fields through various low-altitude flight activities, including manned and unmanned aerial vehicles. The low-altitude economy is centered around the general aviation industry and led by the drone industry, widely manifesting in the primary, secondary, and tertiary industries. The low-altitude economy has attracted significant attention mainly due to the combined effect of three factors. Firstly, policy changes have injected momentum into its development. 2023 At the Central Economic Work Conference held at the end of the year, it was proposed that technological innovation should lead the construction of a modern industrial system, and several strategic emerging industries such as biomanufacturing, commercial spaceflight, and low-altitude economy were identified. Localities have also introduced relevant support policies one after another. 2023 There are a total of 15 Provinces (autonomous regions) have included content related to low-altitude economy in their government work reports, providing strong support for the development of the industry. At the same time, changes in industry regulations have played a key role. The official implementation of the 'Regulations on the Administration of Unmanned Aerial Flight' has provided the industry with clear legal basis and norms, offering a clearer direction for enterprise development. The third is the breakthrough in technology and the maturation of commercial applications. Especially electric vertical takeoff and landing aircraft ( eVTOL With the continuous development of technology, more and more companies are turning their attention to this field. 2023 In [year], iFlytek's EH216-S Obtaining the world's first standard airworthiness certificate, becoming the first to conduct regular commercial flights eVTOL aircraft The product has undoubtedly sparked the interest of more investors and enterprises, driving the rapid development of the entire industry. Currently, many emerging companies have emerged in the domestic market, including Yufeng Future, WoFei Changkong, and Xpeng Huitian. Airworthiness certification plays a crucial role in the low-altitude economy. It ensures the safe operation of electric aircraft in specific operating environments, providing a reliable guarantee for commercial activities. Secondly, an airworthiness certificate is an important legal basis for legally conducting commercial flights, ensuring the standardized development of the industry. At the same time, the verification work during the airworthiness certification process provides guidance for the design, manufacturing, and testing of products, helping to improve the safety and reliability of products. After the evidence collection is complete, eVTOL aircraft There are still some important challenges on the road to commercial operation. The first is the maturity and reliability of technology. Although significant progress has been made in technology, eVTOL aircraft There are still many limitations to commercial operation, and the application scope of aircraft needs further improvement to ensure their safety and reliability. At the same time, optimizing costs and efficiency is also of utmost importance. Manufacturing costs are high, and battery endurance is limited, so it is necessary to reduce costs and improve efficiency to enhance competitiveness. Infrastructure construction is also a key issue, requiring the establishment of charging facilities, takeoff and landing sites, maintenance facilities, and other infrastructure, as well as the formulation of corresponding aviation control regulations and air traffic management systems. Laws, regulations, and insurance also need to be adjusted and improved accordingly to adapt to eVTOL aircraft The need for commercial operation.     Q :    The core of electric vehicles is the 'three electrifications': eVTOL aircraft Is the core also three-electricity-related? Currently in China eVTOL aircraft Have the motors and flight controllers been localized? What are the difficulties in motor and flight controller development? As a new application scenario for the electrification of three-dimensional transportation, eVTOL aircraft The key technologies include batteries, motors, flight control systems, and aircraft structure. In terms of the machine body, the manufacturer is responsible for design, manufacturing, and delivery eVTOL aircraft The fuselage of an aircraft, which is part of the airframe design, needs to consider the overall aerodynamic performance of the aircraft, rotor blade design, etc. It should possess advanced aviation engineering technology, materials science, and manufacturing capabilities to design and manufacture lightweight, sturdy, and safe eVTOL aircraft Bodies. Domestic body suppliers mainly come from general aviation manufacturers, with drone body manufacturers and automotive body manufacturers also having the capability to enter this field. According to current global countries UAM The development trend indicates that only companies that prioritize obtaining airworthiness certification as their primary goal are likely to achieve commercial operations. Focusing solely on the ability of aircraft to fly and fly well is not sufficient to support their business development vision. In terms of flight control, the flight control system is eVTOL aircraft The 'brain', one of its most critical subsystems, is mainly responsible for the perception, control, and decision-making of the aircraft. eVTOL aircraft The flight control technology plays a crucial role in ensuring the safety and reliability of aircraft. Compared to traditional unmanned aerial vehicles, eVTOL aircraft Due to its higher weight and higher requirements for safety, a more complex and intelligent flight control system is needed. Especially in urban areas with complex operating environments, the requirements for controllability and safety are even stricter. Traditional flight control technology covers basic elements such as attitude control and flight trajectory control to ensure that aircraft smoothly and accurately perform special tasks such as vertical takeoff and landing. These basic controls are the cornerstone of ensuring the normal operation of aircraft. However, with eVTOL aircraft With the increasing demand for intelligentization in the market in the future, flight control technology needs to be further developed to meet more complex operational requirements. Currently, domestic manufacturers usually only master one of these technologies. The main domestic flight control suppliers are divided into two categories: traditional military units, research institutes, and universities, such as AVIC Industry. 618 Some companies such as North Aviation, Beihang, and Southern Aviation have strong technical capabilities but higher product prices; another category is emerging private companies like Boundary Intelligence Control and Ansheng, which are involved in military and eVTOL aircraft The domain has rich experience and offers high product value for money. In addition, autonomous driving systems have been applied in civil aviation aircraft, and in the future eVTOL aircraft It will also be required, including Wisk , Volocopter aircraft Companies including Ehang, Yifeng Future, and Zero Gravity are conducting R&D work. In terms of the powertrain, eVTOL aircraft The power system mostly adopts a distributed propulsion system DEP （ Distributed Electric Propulsion Its power redundancy design makes the aircraft safer. NASA and Joby Research shows that DEP The system can achieve the same thrust as a helicopter with three times the efficiency of traditional large engines. High-quality suppliers include: domestic enterprises such as T-Motor (Sanrui Intelligence), headquartered in Nanchang, China, specializes in the research, development, production, and sales of safe and reliable unmanned aerial vehicle power systems; foreign companies such as Pipistrel (Aviation-certified products already available), Safran, Rolls-Royce, MagniX Pending (aviation safety certification). The core of the energy system is lithium batteries. China leads the world in the field of lithium batteries, but currently, there is a lack of full-pack battery suppliers suitable for aviation applications in the market, mainly due to BMS Insufficient selection of battery cells. Therefore, although China has technical capabilities in lithium battery cells, it needs to address the issue of whole-pack batteries and BMS Problems such as [these] still pose certain difficulties.     Q :    eVTOL aircraft What type of battery is being used, ternary or lithium iron phosphate? From the perspective of battery energy density and consistency, is ternary more suitable? eVTOL aircraft Are we using standard electric vehicle batteries, or customized ones? eVTOL aircraft The battery provides energy for the power system and airborne systems. Battery performance is a constraint. eVTOL aircraft The key factor in development. Currently, ternary lithium battery technology is relatively mature and stable, with the highest energy density ratio. In terms of energy density, eVTOL aircraft The demand for energy density far exceeds that of automobiles. Currently eVTOL aircraft The battery is 300 Wh/kg , compared with passenger vehicle ternary batteries ( 200 Wh/kg ) is five percent higher, especially for passenger vehicle lithium iron batteries 140 Wh/kg It is more than twice that of ( ). Even so, 300 Wh/kg The performance metrics still cannot meet the requirements. The battery density can reach 300 Wh/kg , for eVTOL aircraft Relatively considerable endurance is provided, which can approximately support 200 - 250 The flight distance is kilometers. However, in practical applications, battery performance gradually declines with the increase of charge-discharge cycles, which has prompted industry researchers to continuously strive to maintain performance levels while improving battery life.     Q :    currently eVTOL In terms of technical routes, there are mainly multi-rotor, compound wing, and tiltrot technology. What are the respective advantages and disadvantages of these technologies? Promote technology in eVTOL aircraft Design plays a crucial role, as different propulsion technologies directly affect the performance, application scenarios, and technical difficulty of aircraft. Currently, the main propulsion technologies include multi-rotor, compound wings, and vector thrust. Multi-rotor configurations are a common design, providing lift through multiple rotors that simplifies the aircraft structure. They are suitable for short-distance, low-speed flights, such as urban short-range transportation. Although the technical difficulty is relatively low, they are in their initial stages. eVTOL aircraft An ideal choice for development, but it has high energy consumption and limited range and speed. The compound wing configuration uses independent propellers, with cruise and lift provided by different components, suitable for medium-distance urban flights. Although it has lower energy consumption, due to the existence of two sets of power systems, it has a larger self-weight and occupies more space, making it less suitable for urban use. The vector thrust configuration stands out with its advantages in speed and range, providing lift through vector thrusters and cruise lift through wings. It is suitable for long-distance high-speed flight and offers an efficient solution for long-distance urban transportation. However, it is a technically challenging project that requires advanced engineering and control technologies. The choice of different propulsion technologies requires a balance between flight performance, technical difficulty, and specific application requirements. eVTOL As a potential solution for future urban transportation, advancing technology development will directly affect its application in different fields, providing diverse technical pathways for achieving more flexible and efficient air traffic.     Q :    Are the low-altitude economy regulations and laws currently sound and complete? eVTOL aircraft Are there any legal restrictions on low-altitude operations?   At present, China has not yet formed a complete system in terms of low-altitude economic policies and regulations, and there are a series of prominent problems. Firstly, China lacks and lags behind in laws and regulations related to the low-altitude economy, and the guidance on technical standards, application specifications, and flight rules for low-altitude aircraft is not clear enough. In addition, the low-altitude regulatory legal system is not yet sound, and the management mechanism lacks innovation. Currently, the management of low-altitude airspace still continues with the traditional approach of general aviation management, resulting in limited airspace opening, cumbersome flight approval processes, and a scarcity of market-oriented service providers. This is not conducive to the innovative development needs of the low-altitude economy. Therefore, there is an urgent need for the improvement and innovation of policies and regulations to promote the healthy development of the low-altitude economy industry. * This interview has been published in 'Daily Economic News', with reporter Zhu Chengxiang and the original title being '“Will the battery fall off if it breaks?” Live streaming sale begins "How far are we from flying commuter flights after 'airport shuttle'?"

The 2nd Jinling International Conference on Biochemical Analysis Sponsored by Pharmaceutical Phase   The 2nd Jinling International Biochemical Analysis Conference & Exhibition is held at 4 month 18 The event successfully concluded at Nanjing Zijin International Hotel on the 1st. 50 Industry experts from top-tier international and domestic sectors share their experiences, bringing together experts, scholars, industry practitioners, and researchers from all over the country. 500 More than a dozen people gathered together to discuss the cutting-edge technologies, innovation trends, and development opportunities in the pharmaceutical field. The conference features multiple thematic forums, focusing on research on the quality of chemical bulk drugs, preparation quality, proteins, ADC In-depth discussions were held on topics such as pharmaceutical substance control analysis, peptide drug quality research, nucleic acid drug quality research, and the control and analysis of cell gene therapy pharmaceutical substances, providing a rich academic exchange platform for participants.   Frost & Sullivan Frost & Sullivan Zhang Chenyang, Senior Consulting Manager of the Life Sciences Business Unit at Frost & Sullivan (referred to as 'Frost & Sullivan'), was invited to attend the forum and participate in the special topic forum on 'Analysis and Quality Control of Cell and Gene Therapy Drugs', sharing the current market situation and development trends of gene drugs.   Senior Consulting Manager, Life Sciences Business Unit, Frost & Sullivan Greater China Zhang Chenyang Zhang Chenyang pointed out that in recent years, the launch of gene drugs has accelerated, as of 2024 year 2 months, globally, have already 13 A gene therapy has been approved for marketing. 2022 year -2024 year 2 month 7 The drug has been approved for marketing. The delivery systems for the approved products include viruses and plasmids. Among them, AAV Carriers are the most widely used due to their low immunogenicity, different tissue affinities among various subtypes, and relatively mature production processes. 62% The gene therapy market, which has been listed, covers areas such as the blood system, metabolism, circulatory system, neuromusculoskeletal system, and oncology. From the perspective of the capital market, 2023 In the global primary market for gene drugs, several financing events have occurred. Capital continues to favor the gene drug sector, while transactions in the global and Chinese gene drug markets / Cooperation events are frequent, and the competition continues to heat up. Source: Analysis by Frost & Sullivan Zhang Chenyang stated that the research, development, and production of gene drugs pose significant high-tech barriers, mainly reflected in aspects such as delivery system safety, gene editing safety, gene expression regulation, precise targeting of lesions, large-scale production, and product quality control. In the future, with the continuous emergence and advancement of new technologies, the research, development, and production of gene drugs will embrace broader development space. At the same time, its application fields will continue to expand. With diversified payment models and reduced treatment costs, more patients will benefit.   More exciting moments from the event arena About Frost & Sullivan's Life Sciences Practice The Life Sciences Practice of Frost & Sullivan has professional analytical capabilities and extensive project experience in the field of life sciences. Leveraging Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, the Life Sciences Practice has unique core advantages in investment and financing services for the life science industry. The Life Sciences Practice has a wide range of corporate clients in China and in the past 20 In the year, a vast customer network was established, accumulating extensive project experience in various subfields of life sciences. Project types include Knowledge Center projects (in-depth content and promotional activities). Pre-IPO financing project DCF model Valuation, Business Plan Services), IPO listing We provide listed projects (industry consulting, clinical audits, fundraising and investment writing), market research, market value management, and strategic consulting. We also cooperate with well-known domestic and international information platforms and investment and financing institutions to offer one-stop solutions for enterprises in specialized sub-sectors such as pharmaceuticals and medical devices. Our services have received wide attention from investors.

EY Fudan Most Potential Enterprise 2024   2024 The year is a crucial one for achieving the goals and tasks of the 14th Five-Year Plan. The National Two Sessions have pointed out the need to accelerate the development of "new productive forces," which includes three important measures: "promoting the optimization and upgrading of industrial chains and supply chains, actively cultivating emerging and future industries, and deeply advancing the innovative development of the digital economy." As an important driving force for a new round of scientific and technological revolution and industrial transformation, artificial intelligence will bring about revolutionary technological breakthroughs and become an important engine for promoting the development of new productive forces. The future blueprint for the digital economy and artificial intelligence is already in sight. More and more emerging enterprises are turning their attention to artificial intelligence technology, allowing for deep integration with traditional industries to create new development ecosystems.   2024 year 4 month 26 Today, "EY Fudan Most Promising Companies" 2024 The selection activity was officially launched today, and registration from all sectors has begun as of now.   After fourteen years, this selection will feature “Future World· Artificial Intelligence N.0 With the theme of 'Discovering and Supporting Non- Listed Companies with Excellent Performance and Growth Potential', we aim to identify a group of companies that are poised to become industry leaders by rapidly growing their business.     Frost & Sullivan Frost & Sullivan Frost & Sullivan, the co-organizer of this selection process, was represented by Dr. Wang Xin, Global Partner and Chairman of Frost & Sullivan Greater China, as a member of the selection committee and a representative of the co-organizers at the launch ceremony, where he delivered a welcome speech. EY Greater China Business Partner Bi Shunjie   Bing Shunjie, Partner-in-Chief of EY Greater China, said   : "At present, technological innovation has provided an important impetus for developing new quality productivity. With the vigorous development of a new round of scientific and technological revolution and industrial transformation, China is embracing unprecedented historical opportunities. For enterprises, cultivating and strengthening new quality productivity is a systematic project that requires long-term investment. We have seen a large number of enterprises accelerating breakthroughs based on actual application scenarios." 5G We are actively developing cutting-edge technologies such as artificial intelligence, blockchain, and digital twins to build an internationally advanced, secure, and controllable technology system. We are making early arrangements for future industries, accelerating the transformation and upgrading of existing industries, and providing strong support for modern high-quality development. This year's judging panel continues to be composed of partners from EY's member firms and senior experts and scholars from the School of Management at Fudan University. The selection will adhere to professional, objective, and open criteria, based on a series of key indicators such as industry attributes, development models, and innovation capabilities, to identify enterprises with outstanding performance, healthy growth trajectories, and great potential for development. EY Hong Kong EMEA Listed Services Partner He Zhaofeng     He Zhaofeng, Head of Listing Services for Greater China at EY, said:     "With the in-depth development of a new round of technological revolution and industrial transformation, new productive forces such as artificial intelligence, digital economy, and virtual reality have shown broad development prospects. As one of the world's leading professional service institutions, EY has long been committed to assisting enterprises in their multi-faceted growth, contributing more wisdom and strength to emerging enterprises in exploring new drivers, cultivating new productive forces, and sustainable development. This year, EY once again joined hands with the School of Management at Fudan University to hold the 'EY-Fudan Most Potential Enterprise' selection event, aiming to continue to discover emerging enterprises that can seize opportunities of the times and invest in digital technology transformation, helping them achieve leapfrog development." Professor, Doctoral Supervisor at Fudan University, Deputy Dean of the School of Management at Fudan University Lv Changjiang Global Partner and Chairman of Frost & Sullivan Greater China Region Dr. Wang Xin   Dr. Wang Xin, Global Partner at Frost & Sullivan and Chairman of the Greater China Region, said:   "The prosperity of the capital market is closely linked to the rise of high-quality emerging enterprises, which promote and coexist with each other. As the source of market vitality, the rapid development of emerging enterprises cannot be separated from the strong support of the capital market; and the activity of the capital market provides these enterprises with broader development space and financing opportunities. This year marks the fourth time that Frost & Sullivan has served as a co-supporting institution for the selection of the most potential enterprises at EY Fudan. We will continue to leverage our professional strengths in industry analysis, market insight, and investment and financing consulting, deeply participating throughout the nomination and evaluation process, fully cooperating with the event, jointly promoting the growth and development of outstanding enterprises, and injecting new vitality into the prosperity of the capital market."   Dr. Wang Xin pointed out that in recent years, artificial intelligence is profoundly changing the era we live in with its rapid development momentum. 'EY Fudan Most Potential Enterprise' 2024 The selection event is themed 'Future World & Artificial Intelligence'. N.0 " themed, not only AI The specific manifestation of iterative upgrading of industrial practice is, more so, a AI An in-depth analysis and exploration of industry frontier exploration, innovation-driven development, and benchmarking for value shaping. As a globally leading investment, financing and corporate growth consulting firm, Frost & Sullivan has always focused its research on high-growth, strategic and leading industries. Especially in the field of artificial intelligence, Frost & Sullivan has accumulated over 2,000 This original research report covers all aspects of the industry in depth.   Frost & Sullivan has not only successfully assisted numerous AI Enterprises have achieved remarkable success in the capital market and are also actively embracing digital transformation, exploring AI Empowered new-generation industry research. "Frost & Sullivan attaches great importance to this opportunity as a cooperative supporting institution and is deeply honored to work with outstanding partners such as EY and Fudan to jointly promote the 'EY Fudan Most Potential Enterprise' selection event. While uncovering corporate value and witnessing industry glory, we will continue to leverage our comprehensive investment management services capabilities in market insight, strategic planning, capital operations, and more."   We look forward to deepening cooperation with all parties to provide more precise, efficient, and forward-looking guidance for future industry leaders. At the same time, we will build a broader resource docking platform to help them accelerate growth on key tracks such as artificial intelligence and lead industry innovation and development.   "Dr. Wang Xin said." Recommended Reading recently AI Domain-Specific White Papers   1 Frost & Sullivan, in collaboration with LeadLeo Research Institute, released 2024 China Large Model Evaluation Report 2023         2 Frost & Sullivan, in collaboration with LeadLeo Research Institute, released 2023 Year in China AI Development Platform Market Report         3 Frost & Sullivan, in collaboration with LeadLeo Research Institute, released 2023 Year in China AI Large Model Research Capability Evaluation Report         4 Frost & Sullivan releases 'China AI Basic Software Market Research Report 2023 )》         5 Frost & Sullivan, in collaboration with LeadLeo Research Institute, released 2023 Year in China AI White Paper on Technology-Driven Enterprise Services         6 Frost & Sullivan releases 2023 Year in China AI White Paper on Large Model Industry       AI Industry Advisory Cases (Scroll up and down to view more) ·            Frost & Sullivan assistance Lucas GC Limited Successfully listed in the US (LGCL.NASDAQ) ·          Frost & Sullivan assisted Ebuy International in successfully going public in Hong Kong (9880.HK) ·          Frost & Sullivan assisted Beck Microelectronics in successfully listing on the Hong Kong Stock Exchange (2149.HK) ·          Frost & Sullivan assisted Wel Group in successfully listing on the Hong Kong Stock Exchange GDR(WILL) ·          Frost & Sullivan assisted Conglian Technology in successfully going public in the US (NASDAQ:ICG) ·          Frost & Sullivan helps SMBs i The robot was successfully listed in the US (NASDAQ:AIXI) ·          Frost & Sullivan assisted Jinshan Cloud Holdings in successfully going public on the Hong Kong Stock Exchange (3896.HK) ·          Frost & Sullivan assisted Haojing Technology in successfully going public in Hong Kong (2440.HK) ·          Frost & Sullivan assisted Xuanwu Cloud Technology in successfully going public in Hong Kong (2392.HK) ·          Frost & Sullivan assisted Huitongda in successfully going public in Hong Kong (9878.HK) ·          Frost & Sullivan assists innovative start-ups in successfully listing on the Hong Kong Stock Exchange (2121.HK) ·          Frost & Sullivan assisted SenseTime in successfully going public in Hong Kong (0020.HK) ·            Frost & Sullivan assisted Qinhuai Data in successfully going public in the US (NASDAQ: CD) ·          Frost & Sullivan assisted Mingyuan Cloud in successfully going public in Hong Kong (0909.HK) ·          Frost & Sullivan assisted Aurora Mobile in successfully going public in the US (NASDAQ: JG) ·          Frost & Sullivan assisted Crown Holdings in successfully listing on the Hong Kong Stock Exchange (8606.HK) ·          Frost & Sullivan assisted Qiyi Technology in successfully going public in Hong Kong (1739.HK) ·          Frost & Sullivan assistance Zioncom Successfully listed on the Hong Kong stock market (8287.HK) ·          Frost & Sullivan assistance Vobile Successfully listed on the Hong Kong stock market (3738.HK) ·          Frost & Sullivan assisted Abbot Technology in successfully going public in Hong Kong (2708.HK) ·          Frost & Sullivan assistance iClick Successfully listed in the US (NASDAQ:ICLK) ·          Frost & Sullivan assisted Anling International in successfully listing on the Hong Kong Stock Exchange (8410.HK) ·          Frost & Sullivan assistance Future Data Successfully listed on the Hong Kong stock market (8229.HK) ·          Frost & Sullivan assisted Asia Backup in successfully going public in Hong Kong (8290.HK) * The above order is not sequential and is arranged in reverse chronological order by listing time.

The 3rd Frost & Sullivan Industry Development and Innovation Forum on Peptide and Nucleic Acid Drugs   In recent years, peptide and nucleic acid drugs have witnessed rapid development. Peptide drugs have advantages such as high activity, low dosage, and low toxicity; nucleic acid drugs have benefits such as rich targets, short R&D cycles, long-lasting efficacy, and high clinical development success rates. A large number of pharmaceutical companies have been deploying in the peptide and nucleic acid drug market in recent years; however, they still face challenges in terms of small molecular weight, short half-life, administration methods, stability, delivery technology, production, and more.   On April 12, 2024, the 3rd Frost & Sullivan Industry Development and Innovation Forum on Peptide and Nucleic Acid Drugs, hosted by E-P Pharmacy Garden and focusing deeply on peptide, PDC, and nucleic acid drugs, successfully opened by the lakeside of Gusu Lake. The conference, centered around the theme "New Core Technologies for Building New Peptides," gathered nearly 800 professionals and industry elites in the field of peptide and nucleic acid drugs in Suzhou.   Zhang Chenyang, Senior Consulting Manager of the Life Sciences Business Unit of Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") Greater China region, was invited to attend the forum and delivered a keynote speech on "Analysis of the Current Situation and Development Trends of the Global Peptide Drug Market." Zhang Chenyang, Senior Consulting Manager of the Life Sciences Business Unit of Frost & Sullivan Greater China region   Zhang Chenyang pointed out that peptide drugs were initially used in the field of diabetes treatment. However, with the development and innovation of new peptide drugs, their application areas have been continuously expanding. In recent years, they have gradually extended to the field of obesity, achieving an important transformation. Data shows that the global GLP1R peptide drug market has grown rapidly, with a rapid increase in sales as weight loss indications were approved, high consumer demand, reaching $254 billion in 2022, and it is expected to reach $908 billion by 2030. At the same time, the growth rate of the GLP1R peptide drug market has driven the rapid growth of the peptide drug market, reaching $754 billion in 2022. Under the continuous influence of GLP1R peptide drugs, it is expected that the overall peptide drug market will reach $2108 billion by 2030. Among them, the market scale of peptide drugs in China has also increased year by year with the global market scale, maintaining a proportion of about 15% in the global peptide drug market scale. Source: Frost & Sullivan analysis   Zhang Chenyang said that the Chinese peptide drug market started relatively late. However, with the gradual improvement of China's peptide drug production industrial chain, the number of BE clinical trials for Chinese peptide drugs has risen rapidly, and many domestic generic drug manufacturers have encountered huge development opportunities.   “The aging trend in our country is becoming increasingly significant, accompanied by a significant increase in the demand for chronic disease treatment caused by population aging. At the same time, the acceptance of peptide drugs in clinical applications is constantly increasing, which has led to strong growth trends in both generic and innovative peptide drugs. In addition, a professional CRDMO model will also provide strong support for the vigorous development of China's peptide drug market. Looking ahead, the development potential of China's peptide drug market is huge and the prospects are broad.” Zhang Chenyang said.   More highlights from the event About the Life Sciences Business Unit of Frost & Sullivan   The Life Sciences Business Unit of Frost & Sullivan has professional analytical capabilities and rich project experience in the field of life sciences. Relying on Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, the Life Sciences Business Unit of Frost & Sullivan has unique core advantages in life science industry investment and financing services. The Life Sciences Business Unit of Frost & Sullivan has a wide range of corporate clients in China and has established a vast customer network over the past 20 years, accumulating a large amount of project experience in various sub-sectors of life sciences.   Project types include knowledge center projects (in-depth content, promotional activities), Pre-IPO projects (DCF valuation, business plan services), IPO listing projects (industry consultants, clinical audits, fundraising writing), market research, market value management, and strategic consulting, etc., and cooperate with well-known domestic and international information platforms and investment and financing institutions to provide one-stop solutions for professional sub-sectors such as pharmaceuticals and medical devices for enterprises, attracting wide attention from investors.

Although the technological iteration of humanoid robots still requires time, two forces in the current market are trying to accelerate their transformation from 0 to 1 to achieve commercialization and implementation of products. What are the respective advantages and disadvantages of large manufacturers, new energy vehicle companies, and specialized robot companies in developing humanoid robots? When is it expected that humanoid robots will truly enter automotive assembly workshops? If measured by 100% the criteria for implementation, what level has the current technology and product reached? What challenges still exist in the current automotive manufacturing scenarios? Compared with existing mature industrial robots, what are the advantages of humanoid robots on automotive assembly lines? Will general-purpose humanoid robots replace industrial robots? What is the current level of the 'brain' of humanoid robots on the market? What are the requirements for large models to be adapted to the 'brain' of humanoid robots?     Frost & Sullivan ( Frost & Sullivan , hereinafter referred to as 'Frost & Sullivan') Executive Director for Greater China, Cui Nan, was interviewed by the Financial Times magazine to discuss the above topics.   Financial Times   * Click at the end of the article Read the original article to view the complete report     Q ：    What are the respective advantages and disadvantages of large manufacturers, new energy vehicle companies, and specialized robot companies in developing humanoid robots? The advantage of new energy vehicle companies lies in their control over hardware costs and their mature experience in autonomous driving applied to the development and manufacturing of humanoid robots, but there may be limitations in downstream scenarios. The advantage of specialized robot companies lies in their rich understanding of the industry, having accumulated a large number of professionals and specialized robot technologies earlier, but they also need capital support. Large manufacturers, relying on their ecological advantages and integration capabilities, can quickly conduct robot research and development and implementation, but they started relatively late and lack first-mover advantages.     Q ：    When is it expected that humanoid robots will truly enter automotive assembly workshops? If measured by 100% the criteria for implementation, what level has the current technology and product reached? If measured by 100% the criteria for implementation, what level has the current technology and product reached? The standard is currently at 30% and it is expected that it will take 5-10     years to see humanoid robots widely applied in automotive assembly workshops. Q    What challenges still exist in the current automotive manufacturing scenarios? The first is the application challenge: The industrial manufacturing field has very strict requirements for the precision and efficiency of robot work, making it difficult for humanoid robots to match the already mature industrial mobile robot products; the second is the cost challenge, as advanced technology and complex engineering make the production cost of humanoid robots higher than that of mature industrial robots, which limits their popularity and practicality at this stage.     Q ：    Compared with existing mature industrial robots, what are the advantages of humanoid robots on automotive assembly lines? Will general-purpose humanoid robots replace industrial robots? Many tasks on the automotive assembly line, such as installing car interiors, applying car stickers, and gluing glass windows, are difficult for ordinary industrial robots to replace humans with. This is because the structure of a car is designed entirely according to the characteristics of human movement, and ordinary industrial robots cannot bend and squat freely like humans to perform some assembly work. Relatively speaking, humanoid robots have more flexible movement capabilities and are suitable for some parts of the automotive manufacturing line. Humanoid robots will not completely replace the roles of existing industrial robots; they will more likely automate positions still operated by humans. The value of humanoid robots lies in maximizing the utilization of existing infrastructure in human society, simulating human activities to the greatest extent possible, and achieving automation and intelligent improvement.     Q ：    Most in the industry believe that both 3C and automotive manufacturing are suitable for first implementation, but from the current dynamics of robot manufacturers, it seems that they place more emphasis on automotive manufacturing scenarios. So compared to 3C , does automotive manufacturing have more unique advantages? From a technical perspective, 3C scenarios have more refined parts compared to automotive, and there are higher requirements for the precision of robot execution capabilities, so manufacturers will give priority to automotive manufacturing scenarios.     Q ：    What is the current level of the 'brain' of humanoid robots on the market? What are the requirements for large models to be adapted to the 'brain' of humanoid robots? The main technology of a robot's brain is artificial intelligence. Artificial intelligence is mainly divided into three stages: narrow AI, general AI, and super AI. Narrow AI, also known as weak AI, refers to AI that performs specific tasks or limited-range tasks, such as facial recognition and voice recognition. This is the most common type of AI and the level that current humanoid robot 'brains' can achieve. As an ideal carrier of embodied intelligence, humanoid robots not only need to break down a specific task into specific subtasks at the 'task level' but also need to effectively execute these subtasks to interact with the physical world. Therefore, the execution success rate of a large model of a robot is an important indicator for measuring the degree of robot intelligence. To train the execution success rate of a large model of a robot, the robot needs to have autonomous and reliable decision-making capabilities, multimodal perception capabilities, and precise operation control capabilities. These capabilities require the robot to collect a large amount of data, train models, and conduct simulation tests to truly adapt the large model to the 'brain' of humanoid robots. * This interview has been published in the Financial Times magazine, and the reporter is   Yang Liu    , with the original title '    Humanoid Robots Enter Factories for 'Internship', Do Automotive Manufacturers Still Need Workers?    >

Recently, the China Securities Regulatory Commission (CSRC) issued the "Opinions on Strengthening the Supervision of Listed Companies (Trial)". Among these, in promoting listed companies to strengthen market value management and enhance investment value, it supports listed companies in enhancing their investment value through mergers and acquisitions. Multiple measures have been taken to activate the mergers and acquisitions market, encouraging listed companies to comprehensively use tools such as shares, cash, and targeted convertible bonds to carry out mergers and acquisitions and inject high-quality assets. Data shows that in the first quarter A M&A and restructuring activities in the stock market are active.   In the practice of mergers and acquisitions, what is the key to successfully enhancing a company's investment value through restructuring? Since last year, regulators have frequently encouraged and supported listed companies to engage in mergers and acquisitions. What changes are expected to occur in the market for mergers and acquisitions? How effective have the current measures such as targeted convertible bonds and small-scale rapid transactions been? How should future supervision be strengthened? What new trends and characteristics will emerge in high-quality industrial mergers and acquisitions in the future? How should relevant listed companies seize these opportunities?     Frost & Sullivan Frost & Sullivan Zhou Mingzi, Executive Director of Frost & Sullivan Greater China, was interviewed by Securities Daily to discuss the above topics.   Securities Daily   * Click at the end of the article Read the original text View the full report     Q :    In the practice of mergers and acquisitions, what is the key to successfully enhancing a company's investment value through restructuring? In M&A practice, clarifying the acquisition target is one of the keys to enhancing a company's investment value. Before conducting an acquisition, the company needs to define its strategic objectives and desired outcomes to guide subsequent decision-making and actions. The purposes of a company's M&A restructuring include expanding market share, entering new markets, acquiring key technologies or intellectual property, etc. After establishing clear acquisition targets in the early stages, the company can better screen potential acquisition candidates, ensuring that the chosen targets align with the company's long-term strategy and vision, thereby increasing the probability of success and return on investment in M&A. In addition, ensuring cultural consistency between merging companies is also one of the key factors for successful mergers and acquisitions. Cultures of different companies may vary, and if cultural differences are ignored during the merger process, it can lead to issues such as employee discomfort and team conflicts, thereby affecting the success of the merger. Therefore, after a merger, the acquirer needs to conduct a cultural assessment to understand the target company's culture, values, and work methods, and develop corresponding cultural integration plans. Through active cultural integration, it can promote employee integration and teamwork, helping to achieve business integration and value creation after the merger.     Q :    Since last year, the regulatory authorities have frequently encouraged and supported listed companies' mergers and acquisitions. What changes are expected to occur in the M&A market as a result? How has the implementation of targeted convertible bonds and small-scale rapid transactions been progressing? How should future supervision be strengthened? In the past two years, regulatory authorities have frequently sent positive signals to the market regarding mergers and acquisitions, introducing a number of measures including targeted convertible bonds and small-value quick approvals, aiming to simplify the review process, reduce transaction costs of mergers and acquisitions, and stimulate market vitality. Data shows that since the beginning of this year, there have been approximately 60 home A The number of listed companies disclosing major restructuring events has shown a significant upward trend compared to the same period last year, mainly involving high-end manufacturing industries. Overall, the regulatory authorities' series of merger and restructuring policies have achieved positive results, further highlighting the function of mergers and reorganizations in serving the real economy. Enterprises have grown and strengthened through mergers and reorganizations, enhancing their competitiveness. In the future, to stimulate the vitality of market mergers and reorganizations, regulatory authorities will continue to make efforts to further provide a favorable environment for listed companies' restructuring. Firstly, regulatory authorities can further simplify the review process for mergers and reorganizations, reduce approval procedures and document requirements, and improve approval efficiency. , For example, optimizing the 'small and quick' review mechanism for reorganizations, etc. This will reduce the transaction costs of enterprises and encourage more companies to participate in mergers and acquisitions. Secondly, regulatory authorities can introduce policies to support chain leaders in integrating upstream and downstream industries, and formulate differentiated policies for different industries and enterprise sizes to better promote the integration and upgrading of industrial resources and drive the development of the entire industry. While streamlining processes, regulatory authorities must also strengthen risk management to ensure that the mergers and acquisitions of enterprises comply with laws and regulations and avoid adverse consequences. By simplifying review processes, supporting industrial chain integration, and strengthening risk management, regulatory authorities can provide stronger support for the release of market vitality.     Q :    What new trends and characteristics will emerge from high-quality industrial mergers and acquisitions in the future? How should relevant listed companies seize these opportunities? In the future, high-quality industrial mergers and acquisitions will exhibit several new trends and characteristics. At the same time, listed companies related to these industries also need to develop corresponding countermeasures in response to these trends. Firstly, strategic emerging tracks that align with national policy orientations will become the focus of mergers and acquisitions. With policy support, strategic emerging industries are entering a golden development period. The demand for technological integration and scale expansion among enterprises is increasing day by day. Therefore, encouraged by policies, strategic emerging tracks will become the mainstream trend of mergers and acquisitions in the future. Listed companies should closely follow national policy orientations, seize opportunities in strategic emerging tracks, actively participate in related mergers and acquisitions activities, and enhance their competitiveness in emerging fields. Secondly, the efficiency of mergers and reorganizations will be further enhanced. With the introduction of new policies, there will be a significant reduction in the number of inquiry rounds for eligible restructuring applications, leading to improved review efficiency. Therefore, listed companies need to promptly understand and adapt to the new review mechanism, making preparations in advance to complete mergers and reorganizations more quickly. In addition, future mergers and acquisitions will place more emphasis on the synergistic effects of enterprises and the complementarity of industrial resources. Compared with past speculation and mere scale expansion, future mergers will focus more on how to integrate resources and enhance the core competitiveness of enterprises. Therefore, when conducting mergers and acquisitions, listed companies should pay attention to the connection degree and synergistic effects of their target enterprises with their own industrial chains, so as to achieve complementary advantages and create greater value. Overall, in the future, high-quality industrial mergers and acquisitions will pay more attention to national policy guidance, approval efficiency, and corporate synergy effects. Listed companies need to closely monitor market trends, seize opportunities, rationally utilize merger and reorganization tools, and implement mergers and integrations to enhance their competitiveness and market position. * This interview has been published in 'Securities Daily', with reporters Xie Ruolin and Mao Yirong. The original title was 'First Quarter A M&A and restructuring in the stock market are active Industrial M&A is Becoming the Mainstream

Special Session on Hot Topics in Biopharmaceutical M&A   As mergers and acquisitions in the pharmaceutical industry gradually become more active, pharmaceutical companies should pay attention to resource optimization and integration, as well as industrial synergy during mergers and acquisitions and restructuring. They should conduct in-depth research on the quality of target assets, improve the quality of restructuring transactions, and avoid blind transactions. Only in this way can they truly enhance the development potential of enterprises and achieve the goal of becoming better and stronger. On March 22nd, a special session on hot topics in biopharmaceutical M&A, hosted by the Shanghai Biomedical Industry Promotion Center and co-organized by the Shanghai Free Trade Zone No. 1 Life Science Industrial Park (referred to as 'Xingbei Free Trade Zone No. 1'), was successfully held at the industrial experience center on the first floor of Building 6 in Phase 1 of Xingbei Free Trade Zone No. 1. Yang Jiyuan, Senior Consulting Manager of the Life Sciences Division of Frost & Sullivan (Frost & Sullivan, referred to as 'Frost & Sullivan'), was invited to attend this event. She jointly conducted special exchanges with Shi Qingqing from Jintiancheng Law Firm, Fei Ying, a consulting partner at PwC's M&A advisory practice, and Tao Li, Director of the Shanghai Investment Banking Department at CITIC Construction Investment Securities, for the participants. Yang Jiyuan, Senior Consulting Manager of the Life Sciences Division of Frost & Sullivan   Yang Jiyuan shared on 'The Current Situation and M&A Trends in Biopharmaceutical Investment and Financing'. She pointed out that since 2020, with the gradual tightening of biopharmaceutical IPOs, the amount of investment and financing in China's biopharmaceutical industry has shown a downward trend. In the past five years, global biopharmaceutical M&A transactions have been frequent, with a large number of transactions involving large multinational pharmaceutical companies as buyers worth tens of billions. In contrast, China's share of global biopharmaceutical M&A transactions is small, and the average transaction amount is also significantly higher than the global average. On the other hand, China's biopharmaceutical M&A transactions in the past five years have mainly focused on bulk drugs, traditional Chinese medicine, and innovative drugs. Source: Frost & Sullivan analysis   Yang Jiyuan stated that in the future, there will be three major trends in biopharmaceutical M&A: First, leading companies will continue to integrate resources through mergers; second, under the business essence of 'cost reduction and efficiency improvement', 'complementary capabilities' will become a new logic for upstream and downstream integration in the industry; third, central state-owned enterprises and state-owned assets will gradually become the main force in biopharmaceutical M&A.   About the Life Sciences Division of Frost & Sullivan   The Life Sciences Division of Frost & Sullivan has professional analytical capabilities and rich project experience in the field of life sciences. Relying on Frost & Sullivan's global think tank resources and cross-industry business development platform in Greater China, the Life Sciences Division of Frost & Sullivan has unique core advantages in investment and financing services for the life sciences industry. The Life Sciences Division of Frost & Sullivan has a wide range of corporate clients in China and has established a large customer network over the past 20 years, accumulating extensive project experience in various sub-sectors of life sciences.   Project types include knowledge center projects (in-depth content, promotional activities), Pre-IPO projects (DCF valuation, business plan services), IPO listing projects (industry advisory, clinical audit, fundraising writing), market research, market value management, and strategic consulting, etc. It also collaborates with well-known domestic and international information platforms and investment and financing institutions to provide one-stop solutions for enterprises in professional sub-sectors such as pharmaceuticals and medical devices, attracting widespread attention from investors.